Have a personal or library account? Click to login
A dual strategy to improve psychotic patients’ compliance using sustained release quetiapine oral disintegrating tablets Cover

A dual strategy to improve psychotic patients’ compliance using sustained release quetiapine oral disintegrating tablets

Open Access
|Oct 2016

Abstract

Quetiapine (QT) is a short acting atypical antipsychotic drug effective in schizophrenia and bipolar disorder. This study aims at designing a novel dosage form of sustained release taste-masked QT orally disintegrating tablets (ODTs) based on solid lipid micro-pellets (SLMPs). QT SLMPs were prepared using the hot melt extrusion technique and utilizing three lipid carriers: Compritol, Precirol and white beeswax either alone or in mixtures. They showed sustained QT release and a taste masking effect. The selected QT SLMP was further blended with an aqueous solution containing polyvinylpyrollidone (2.5 %), croscarmellose sodium (2 %) and mannitol (50 %); it was then lyophilized into ODT in a mass ratio of 1:2, respectively. ODTs containing QT SLMPs showed: average wetting time (40.92 s), average oral disintegration time (21.49 s), average hardness (16.85 N) and also imparted suitable viscosity to suspend pellets during the lyophilization process. In conclusion, lyophilization is a promising technique for the formulation of multiparticulate systems into ODTs.

DOI: https://doi.org/10.1515/acph-2016-0041 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 515 - 532
Accepted on: Feb 21, 2016
Published on: Oct 15, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2016 Ahmed Refaat, Magda Sokar, Fatma Ismail, Nabila Boraei, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.